He Fei

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Signaling Pathway

Diabetic Retinopathy

Top Venues

BioMed research international

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yicai Zheng, He Fei
High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma. BioMed research international 2022 (2022)
Yicai Zheng, He Fei
High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma. BioMed research international 2022 (2022)
Yunfeng Jin, Saiyan Bian, Hui Wang, Jiahang Mo, He Fei, Li Li, Tong Chen, Hua Jiang
CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway. Cell death & disease 13 (8) (2022)
Ying Qu, Zhengxu Sun, Yan Yuan, Zifeng Li, Fen Wang, Kunpeng Wu, Huihui Yu, Qiwang Lin, He Fei, Jian Chen, Maoxiang Qian, Yunfeng Cheng, Hua Jiang, Tong Chen
Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8 + T cells. Cell death & disease 13 (7) (2022)
Yicai Zheng, He Fei
High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma. BioMed research international 2022 (2022)
Yiying Li, He Fei, Qiwang Lin, Fan Liang, Yanan You, Ming Li, Mengyao Wu, Ying Qu, Pengfei Li, Yan Yuan, Tong Chen, Hua Jiang
ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers. Oncogene 40 (32) (2021)